Metraipolis › archive › dc_c59dd157d99a
Adverse events associated with cyclophosphamide: A pharmacovigilance study using the FDA adverse event reporting system — Europe PMC PMID:41494018
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41494018
- DOI
- 10.1371/journal.pone.0339757
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:01:23.643Z
- SHA-256 of the archived text
1e6e47ac745adbf50643653ee77ad3b99cf20a97b4cf2fb8448c1fc1831216f6- Stable URL of this page
https://metraipolis.com/documento/dc_c59dd157d99a
How to cite
Adverse events associated with cyclophosphamide: A pharmacovigilance study using the FDA adverse event reporting system — Europe PMC PMID:41494018 — Europe PMC (en), https://europepmc.org/article/MED/41494018 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c59dd157d99a (Metraipolis archive dc_c59dd157d99a, sha256 1e6e47ac745adbf50643653ee77ad3b99cf20a97b4cf2fb8448c1fc1831216f6)
BibTeX
@misc{dcc59dd157d99a,
title = {Adverse events associated with cyclophosphamide: A pharmacovigilance study using the FDA adverse event reporting system — Europe PMC PMID:41494018},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41494018},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c59dd157d99a; sha256 1e6e47ac745adbf50643653ee77ad3b99cf20a97b4cf2fb8448c1fc1831216f6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41494018. Agents can read the archived copy with the MCP tool read_document.